Member Info for GedW

Locking in profits at around 4p/share. There is no doubt that the renewed contracts shows good faith in this tiddler. Past holdings announcement and excellent interims should improve share price upside..

These numbers look good considering the general economic downturn.. Should deliver up good shareholder value.. http://www.londonstockexchange.com/LSECWS/IFSPages/MarketNewsPopup.aspx?id=2099317&source=RNS

In difficult markets. IDOX playing its part in trying to improve shareholder value... http://www.londonstockexchange.com/LSECWS/IFSPages/MarketNewsPopup.aspx?id=2099350&source=RNS

Not bad considering state of economy... http://www.londonstockexchange.com/LSECWS/IFSPages/MarketNewsPopup.aspx?id=2099319&source=RNS

Under English/EU/U S Law no contract can have a clause/s which can waiver or minimise personal injury liability, so when things go wrong the tendency is to sue everyone up the chain until you find the one with the deepest pockets or best insurance cover. , this might be different and more difficult in other Legislatures. As I understand it CUS equipment does not carry out laser eye procedures in Australia, but CUS are an Australian registered Company and Aus too have not approved CUS's procedure possibly to my knowledge. CUS is mainly targeting the Indian and Asian market, so far, and then will presumably move into similar regulated territories. I personally would prefer to have my eyes worked on in the Uk/EU or America using tried and tested methods with some guarantee of legal recourse should things go wrong, rather than go abroad to say in India or other Asia countries, so there must be some reason why CUS is concentrating on that Market rather than Europe and America. I am sure the procedure is perfectly safe and sound but I am suspicious as an investor as to why the lucrative Western market place is not being exploited by CUS. Some of the cosmetic surgery Companies operating abroad will actually offer to pay for health tourism flights and pay for hotel accommodation to attract patients and the waiting lists are shorter. This Co is a "one trick" outfit. If it goes wrong and it cannot sell enough products then it has nothing left.

I accept that CUS has developed an alternative to current proven corrective eye surgery techniques, but so do many other unlisted cosmetic surgery companies out there that make such claims vying for "cosmetic" concious custom.. And no doubt CUS will lobby and attempt to break into the lucrative Western market place. What concerns me is the remoteness of this Company and the lack of transparency. It has been suggested that "why would a southern hemisphere registered Co ply its wares at a EU roadshow"?. I would suspect that there are a lot of potential Asian customers as well as European customers who could be persuaded to visit Asia for corrective eye surgery cheaper than Western licenced alternatives. Another question. Should there be a problem in the procedure who does one sue? is it through Australian Court jurisdiction, English Law or Indian Law that presides over claims of negligence. ???

Can I ask a general question. Has this new revolutionary laser eye procedure acquired European US use approval? I would suspect the next market place moving on from Asia would be the African sub continent where the regulatory regime is even less stringent. I am being far too sceptical possibly but everything points to a business which is far too out of touch..

I appreciate the Indian and Southern hemisphere trades but what about the the more tightly regulated US of A or Europe market ? You will find that the info you pasted is on these boards already weeks ago !!!!

Hi Regorexpress. Are you seriously suggesting that the professional markets makers and the "city" experts have not manipulated this and the FSA have not been watching so intently. There is no panic selling or buying, just normal supply and demand and market forces at play. This stock is so much of a misnomer it is unbelievable. Has anyone bothered to ask the eye correction practioners in the UK or US of A about this technolgy and how it could impact on proved tried and tested methods. All as we have is a new concept that could possibly replace traditional corrective laser eye treatment. and a Co based in the Southern hemisphere with a very much out of date website. As much as I want the share price to rise, it appears to me that all the hype is coming from pshare price rise speculators. The Co has taken very much a back seat and can only confirm that an ex Director has built up a 3.3% stakleholding, hardly enough of a platform to launch any kind of a takeover. Take profits on share price rise and churn profits on weakness but move on to more transparrent targets.

As previously pasted. The londonstockexchange concurs. There is some value here yet to be realised... reasons to be cheerful part 1. http://www.londonstockexchange.com/LSECWS/IFSPages/MarketNewsPopup.aspx?id=2098362&source=RNS

This release should get the share price excited and agitated this session... http://www.londonstockexchange.com/LSECWS/IFSPages/MarketNewsPopup.aspx?id=2098350&source=RNS

Come and blog anything you like at http://fairfaxward.blogspot.com/

The spread is a relative red herring. The reason, as i understand it, the spread is so wide is the "risk" the market maker takes in dealing with any stock it is involved in. We really do not know much about CUS as all its offices and Directors are in the Southern Hemisphere away from UK investor prying eyes. The only reason why this stock rose today is because UK investors were prepared to pay the asking price asked of them by the market makers. The market makers are business people lokking to make a "turn" on their investment. They probably do not carry much of this stock so will take whatever any buyer or seller offers. The broker will get his commission on the trades and the market maker gets rid of the stock that is available for trading. This Co has sunk millions into R & D and now wants a return on its investment so will move heaven and earth to convince the World of the cutting edge laser procedure. And as long as there is a market for the shares investors/traders will be milked.... and some will make nice profits from the market and some will presumably lose out..

This stock, as far as I am aware, is based in Australia, so the Directors over there will not yet be aware of the happenings over here. So one would imagine there will be some statement put out tomorrow regarding the share price movement. Most of the "business" appears to be done in the Southern and Pacific basin, and within the confines of the Australian regulatory regime !!!! The pervasive thread I have woven exposes the strenghts and weaknesses of this Co and I have asked the Head office to offer up some explanation for the possible cause of this sessions share price rise... Anything under .55p appears to be a buying opportunity. There are enough shares to satisfy the market buying demand at the moment. But so far CUS is flavour of the moment. Like to see this Co move from its traditional comfort zone area of trade though...

This stock is clutching at recent highs for dear life.. The market makers will blink first and may well cause the sp to fall. There is no proper market in the shares right now, so I am waiting for the sp to drift in order to mop up on weakness. Fresh funding and the new shares will be absorbed by the market on the qt leading to some shareholder value after some expected weakness which will present another buying in opportunity...

It was not difficult to trade this stock. I executed a few hundred k packets today on those shares that were took at mid 20s within a minute or so of placing sell order and got just above bid quote. The problem with this stock is the Aussie directors will not know the "crack" until they read the newspapers over their breakfasts and will then pass instructions to the london stock exchange that they are not aware of matters that would cause the sp to rise so much. But seasoned investors know otherwise....

This secondary offer will enable AGLD fast track its Simberi Papau New Guinea operations... http://www.londonstockexchange.com/LSECWS/IFSPages/MarketNewsPopup.aspx?id=2097614&source=RNS

Follow the money for some good share price upside... http://www.londonstockexchange.com/LSECWS/IFSPages/MarketNewsPopup.aspx?id=855876&source=NEWS

Have now been released to the market, these show the extent of the credit crisis has impacted on trade. Although losses have increased, cash balance remains within safety zone. Trading in the shares resumes today....

Institutional holders and Directors very very very rarely trade the stock of which they are involved. I would be inclined to follow their lead for medium longer term upside. The Co must however turn its laser technology into good hard lucrative contracts. So far it mainly targhets Asia. So it must at all costs break into the established older laser treatment market. I am sure it will attract a lot of interest.